SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001072613-20-000098
Filing Date
2020-02-13
Accepted
2020-02-13 16:51:45
Documents
1
Group Members
ARCH VENTURE FUND VIII OVERAGE, L.P.ARCH VENTURE PARTNERS VIII, L.P.ARCH VENTURE PARTNERS VIII, LLCCLINTON BYBEEKEITH CRANDELLROBERT NELSEN

Document Format Files

Seq Description Document Type Size
1 ARCH VENTURE FUND VIII, L.P. - HOMOLOGY MEDICINES, INC. -- SCHEDULE 13G/A(#1) archviii-homology_13g18372.htm SC 13G/A 286007
  Complete submission text file 0001072613-20-000098.txt   287698
Mailing Address 8755 W. HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631
Business Address 8755 W. HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631 776-380-6600
ARCH Venture Fund VIII, L.P. (Filed by) CIK: 0001605598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address ONE PATRIOTS PARK BEDFORD MA 01730
Business Address ONE PATRIOTS PARK BEDFORD MA 01730 781-301-7277
Homology Medicines, Inc. (Subject) CIK: 0001661998 (see all company filings)

IRS No.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90433 | Film No.: 20611577
SIC: 2834 Pharmaceutical Preparations